| Literature DB >> 29903021 |
Michael Friedrich1, Erik Nowe2,3, Dirk Hofmeister2, Susanne Kuhnt2, Katja Leuteritz2, Annekathrin Sender2, Yve Stöbel-Richter4, Kristina Geue2.
Abstract
BACKGROUND: Young adult patients with cancer have to deal with their disease in an eventful phase of life. A common side effect of cancer and its treatment is cancer-related fatigue (CRF), a phenomenon which can thwart successful coping with developmental tasks. The aims of this study were to assess the psychometric properties of the EORTC QLQ-FA12, a new instrument for assessing physical, emotional and cognitive fatigue, in young adults with cancer, and to propose a cut-off value that indicates a need for further more specific diagnostics.Entities:
Keywords: Cancer-related fatigue; Discriminant validity; Psychometric properties; Roc analysis; Young adults with cancer
Mesh:
Year: 2018 PMID: 29903021 PMCID: PMC6002999 DOI: 10.1186/s12955-018-0949-0
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.186
Items assigned to the diagnostic criteria
| Instrument |
|
| Measured trait | health related quality of life and symptoms in cancer patients |
| Selected items (corresponding scale) | c10, c12, c18 ([physical] fatigue); |
| Instrument |
|
| Measured trait | cancer-related fatigue |
| Selected items (corresponding scale) | fa13_11 (dropped in QLQ-FA12); |
| Instrument |
|
| Measured trait | anxiety and depression in physically impeded patients |
| Selected items (corresponding scale) | ha1, ha6 (subscale anxiety) |
| Instrument | |
| Measured trait | perceived supportive care needs |
| Selected items (corresponding scale) | s2 (subscale physical and daily living need) |
Sociodemographic and medical characteristics of the sample (n = 577)
| Sociodemographic characteristics | |
|---|---|
| Sex | 577 (100.0) |
| Male | 153 (26.5) |
| Female | 424 (73.5) |
| Age at Interview (M = 30.3, SD = 6.1) | 577 (100.0) |
| 18 to < 26 years | 164 (28.4) |
| 26 to < 42 years | 413 (71.6) |
| Education | 573 (100.0) |
| No educational degree/student | 6 (1.0) |
| Basic educational degree (< 10 years) | 37 (6.5) |
| Secondary educational degree (10 years) | 190 (33.2) |
| Highschool degree (> 10 years) | 340 (59.3) |
| Medical characteristics | N (%) |
| Age at Diagnosis (M = 29.3, SD = 6.1) | 577 (100.0) |
| 18 to < 26 years | 184 (31.9) |
| 26 to < 40 years | 393 (68.1) |
| Time since Diagnosis (M = 11.9, SD = 8.0) | 577 (100.0) |
| up to 2 months | 8 (1.4) |
| > 2 to 4 months | 38 (6.6) |
| > 4 to 6 months | 69 (12.0) |
| > 6 to 12 months | 269 (46.6) |
| > 12 to 24 months | 145 (25.1) |
| more than 24 months | 48 (8.3) |
| Diagnosis | 577 (100.0) |
| Breast Cancer [C50] | 150 (26.0) |
| Hodgkin Lymphoma [C81] | 99 (17.2) |
| Gynecological Cancer [C51-C57] | 51 (8.8) |
| Testicular Cancer [C62] | 50 (8.7) |
| Non-Hodgkin Lymphoma [C82-C90] | 42 (7.3) |
| Haematological Cancer [C91-C95] | 38 (6.6) |
| Thyroid Cancer [C73] | 32 (5.5) |
| Gastrointestinal Cancer [C15-C26] | 29 (5.0) |
| Sarcoma [C40-C41, C46-C49] | 26 (4.5) |
| Melanoma [C43] | 19 (3.3) |
| Other C, D00-D48 and Carcinoma in situ | 41 (7.1) |
| Therapiesa, b | 577 (100.0) |
| Chemotherapyc | 443 (76.8) |
| Radiotherapyd | 264 (45.8) |
| Surgery | 427 (74.0) |
| Neither chemo- nor radiotherapy | 85 (14.7) |
amultiple answers possible; b Due to further validation of data there are deviations to the baseline medical therapies published in the study protocol [49].; c including Radio-Chemotherapy; d including nuclear therapies and Radio-Chemotherapy
Fig. 1Model 1 (EORTC QLQ-FA12 Model). Linear arrows show standardized regression weights. Curved arrows show correlations. Values above or under (variable fa12) the rectangles show squared multiple correlations (SMC, item reliabilities for fa1 to fa10, explained variance for variables fa11 and fa12). Variables fa11 and fa12 correspond to items fa12 and fa13 of the former version EORTC QLQ-FA13 in this order
Model Fit (n = 577)
| Model-Fit | Chi2(df) | p | Chi2/df | CFI | TLI | SRMR | RMSEA (90%-CI) | AIC | |
|---|---|---|---|---|---|---|---|---|---|
| M1. | EORTC-FA12 Model | 266.2 (47) | < 0.001 | 5.7 |
| 0.973 |
| 0.09 (0.08–0.10) | 352.2 |
| M2. | General Fatigue Score | 180.2 (32) | < 0.001 | 5.6 |
| 0.948 |
| 0.09 (0.08–0.10) | 246.3 |
| M3. | General Fatigue Index | 837.9 (35) | < 0.001 | 23.9 | 0.800 | 0.743 | 0.091 | 0.20 (0.19–0.21) | 897.9 |
CFI (comparative fit index), TLI (Tucker-Lewis-Index), SRMR (standardized root mean square residual), RMSEA (Root Mean Square Error of Approximation), AIC (Akaike’s Information Criterion). Bold values indicate acceptable fit (CFI ≥ 0.95 or SRMR≤0.06)
Discriminant and convergent validity for model M1 (n = 577)
| Domain | Physical | Emotional | Cognitive | CR | Cronbach’s Alphaa |
|---|---|---|---|---|---|
| Physical fatigue |
|
|
| 0.920 | 0.918 |
| Emotional fatigue | 0.697 |
|
| 0.892 | 0.891 |
| Cognitive fatigue | 0.638 | 0.698 |
| 0.742 | 0.732 |
Above the diagonal (underlined values): squared correlations (r2). On the diagonal (bold values): average variance extracted (AVE). Below the diagonal: correlations (r). Discriminant validity is indicated if AVED1 > r2(D1,D2) and AVED2 > r2(D1,D2) and convergent validity if composite reliability CR > 0.6.; a based on standardized items
ROC analysis (n = 548)
| Cutoff (case ≥ ...) | Value (95% CI) | |||||
|---|---|---|---|---|---|---|
| SEN | SPE | Youden J | PPV | NPV | ACC | |
| 8 | 98 (96–100) | 53 (48–57) | 0.51 (0.48–0.53) | 37 (31–42) | 99 (98–100) | 63 (59–67) |
| 9 | 97 (93–100) | 60 (55–65) | 0.57 (0.53–0.59) | 40 (34–46) | 98 (97–100) | 68 (64–72) |
| 10 | 94 (90–98) | 66 (61–70) | 0.60 (0.56–0.62) | 43 (37–49) | 98 (96–99) | 72 (68–75) |
| 11 | 92 (88–97) | 71 (67–75) | 0.64 (0.60–0.66) | 47 (41–53) | 97 (95–99) | 76 (72–79) |
| 12 |
|
|
|
|
|
|
| 13 | 89 (83–95) | 81 (77–84) | 0.70 (0.66–0.73) | 56 (49–63) | 96 (94–98) | 82 (79–86) |
| 14 | 83 (76–90) | 83 (79–86) | 0.66 (0.62–0.69) | 57 (50–65) | 95 (92–97) | 83 (80–86) |
| 15 | 81 (74–88) | 86 (83–90) | 0.67 (0.63–0.71) | 62 (55–70) | 94 (92–96) | 85 (82–88) |
| 16 | 72 (64–80) | 89 (86–92) | 0.62 (0.57–0.65) | 65 (57–73) | 92 (89–95) | 86 (83–89) |
| 17 | 62 (53–71) | 92 (89–94) | 0.54 (0.49–0.58) | 67 (59–76) | 90 (87–93) | 85 (82–88) |
| 18 | 52 (43–61) | 94 (92–96) | 0.46 (0.41–0.51) | 70 (61–80) | 88 (85–91) | 85 (82–88) |
Cut-off values for the general fatigue index (0–30). SEN (sensitivity) SPE (specificity), PPV (positive predicted value), NPV (negative predicted value), ACC (accuracy). Values with SEN or SPE below 50% are not presented